Nonlinear association between triglyceride-glucose index and risk of hyperuricemia in early-stage cardiovascular-kidney-metabolic syndrome: a cross-sectional study of United States population

The TyG index may serve as a valuable biomarker for identifying hyperuricemia risk in individuals with early-stage CKM syndrome, offering potential utility in clinical and public health settings. Further longitudinal studies are warranted to confirm these findings and assess the impact of TyG index-guided interventions on CKM syndrome progression.